Top 5 diabetes news reports from 2017

Endocrine Today has compiled a list of the top five diabetes news reports posted in 2017.

Healio.com/Endocrinology readers were interested in metformin for conditions beyond type 2 diabetes management, diabetes management in school, vegan diets and type 2 diabetes, and much more.

Beyond diabetes, metformin may prove to be a ‘wonder drug’

In the past 2 decades, metformin has become a mainstay of type 2 diabetes management and is now the recommended first-line drug for treating the disease in the United States and worldwide. Read more.

Communication, careful planning ensure students with diabetes can succeed at school

Type 1 diabetes remains one of the most common chronic diseases of childhood. According to the ongoing SEARCH for Diabetes in Youth study, about 200,000 U.S. children and adolescents have type 1 diabetes. By 2050, that number is expected to rise to 600,000, according to JDRF. Read more.

Vegan diet may be right choice for managing type 2 diabetes

Susan Weiner, MS, RDN, CDE, CDN, talks to Meghan Jardine, MS, MBA, RD, LD, CDE, about the role of plant-based nutrition in the management of type 2 diabetes. Read more.

CDC task force recommends engagement with community health workers for diabetes prevention

Interventions that utilize community health workers for diabetes prevention, typically implemented in underserved communities, can improve health and reduce health disparities for adults with diabetes, according to a recent report released by a CDC task force. Read more.

FDA approves expanded CV indication for Victoza

The FDA approved an expanded indication for the GLP-1 receptor agonist liraglutide to include language in the prescribing information that the drug can reduce risk for major adverse cardiovascular events, myocardial infarction, stroke and cardiovascular disease in adults with type 2 diabetes and established CVD, according to a press release from Novo Nordisk. Read more.